{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:18:19Z","timestamp":1715300299951},"reference-count":14,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.1248\/bpb.b22-00279","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T22:12:45Z","timestamp":1659305565000},"page":"1208-1212","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of Spred\/Sprouty Expression in the Skin of a Contact Dermatitis-Like Model"],"prefix":"10.1248","volume":"45","author":[{"given":"Hiroyasu","family":"Sakai","sequence":"first","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koya","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikoi","family":"Kosugi","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kiyama","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risako","family":"Kon","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutomo","family":"Ikarashi","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzo","family":"Kamei","sequence":"additional","affiliation":[{"name":"Juntendo Advanced Research Institute for Health Science, Juntendo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Physiology and Molecular Sciences, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Hosoe","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Pharmacology, School of Pharmacy, Hoshi University"},{"name":"Department of Bioregulatory Science, School of Pharmacy, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Brites GS, Ferreira I, Sebastiao AI, Silva A, Carrascal M, Neves BM, Cruz MT. Allergic contact dermatitis: from pathophysiology to development of new preventive strategies. <i>Pharmacol. Res.<\/i>, <b>162<\/b>, 105282 (2020).","DOI":"10.1016\/j.phrs.2020.105282"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mittermann I, Aichberger KJ, Bunder R, Mothes N, Renz H, Valenta R. Autoimmunity and atopic dermatitis. <i>Curr. Opin. Allergy Clin. Immunol.<\/i>, <b>4<\/b>, 367\u2013371 (2004).","DOI":"10.1097\/00130832-200410000-00007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. <i>J. Invest. Dermatol.<\/i>, <b>129<\/b>, 31\u201340 (2009).","DOI":"10.1038\/jid.2008.106"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Christensen AD, Haase C. Immunological mechanisms of contact hypersensitivity in mice. <i>APMIS<\/i>, <b>120<\/b>, 1\u201327 (2012).","DOI":"10.1111\/j.1600-0463.2011.02832.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mason JM, Morrison DJ, Basson MA, Licht JD. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. <i>Trends Cell Biol.<\/i>, <b>16<\/b>, 45\u201354 (2006).","DOI":"10.1016\/j.tcb.2005.11.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Masoumi-Moghaddam S, Amini A, Morris DL. The developing story of Sprouty and cancer. <i>Cancer Metastasis Rev.<\/i>, <b>33<\/b>, 695\u2013720 (2014).","DOI":"10.1007\/s10555-014-9497-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bundschu K, Walter U, Schuh K. Getting a first clue about SPRED functions. <i>BioEssays<\/i>, <b>29<\/b>, 897\u2013907 (2007).","DOI":"10.1002\/bies.20632"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yoshimura A. Regulation of cytokine signaling by the SOCS and Spred family proteins. <i>Keio J. Med.<\/i>, <b>58<\/b>, 73\u201383 (2009).","DOI":"10.2302\/kjm.58.73"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Leeksma OC, Van Achterberg TA, Tsumura Y, Toshima J, Eldering E, Kroes WG, Mellink C, Spaargaren M, Mizuno K, Pannekoek H, de Vries CJ. Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1. <i>Eur. J. Biochem.<\/i>, <b>269<\/b>, 2546\u20132556 (2002).","DOI":"10.1046\/j.1432-1033.2002.02921.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Minowada G, Jarvis LA, Chi CL, Neubuser A, Sun X, Hacohen N, Krasnow MA, Martin GR. Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. <i>Development<\/i>, <b>126<\/b>, 4465\u20134475 (1999).","DOI":"10.1242\/dev.126.20.4465"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ding W, Bellusci S, Shi W, Warburton D. Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, <b>287<\/b>, L52\u2013L59 (2004).","DOI":"10.1152\/ajplung.00430.2003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kawazoe T, Taniguchi K. The Sprouty\/Spred family as tumor suppressors: Coming of age. <i>Cancer Sci.<\/i>, <b>110<\/b>, 1525\u20131535 (2019).","DOI":"10.1111\/cas.13999"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Cheng JC, Chang HM, Xiong S, So WK, Leung PC. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. <i>Oncotarget<\/i>, <b>7<\/b>, 81645\u201381660 (2016).","DOI":"10.18632\/oncotarget.13162"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sakai H, Sato K, Sato F, Kai Y, Mandokoro K, Matsumoto K, Kato S, Yumoto T, Narita M, Chiba Y. Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling. <i>Inflamm. Res.<\/i>, <b>66<\/b>, 663\u2013678 (2017).","DOI":"10.1007\/s00011-017-1048-0"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/8\/45_b22-00279\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:30:27Z","timestamp":1715232627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/8\/45_b22-00279\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00279","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"article-number":"b22-00279"}}